FDA Brief

Warning letters Food

FDA warning letter to

Baits and Sea Foods, S.A.

High riskIssued Jun 30, 2023Posted Jul 25, 2023Center for Food Safety and Applied Nutrition (CFSAN)

FDA warns Baits and Sea Foods, S.A. over missing histamine, botulinum and allergen controls in mahi-mahi HACCP plan.

What happened

FDA conducted a Foreign Remote Regulatory Assessment of the seafood processing facility on May 8 through 11, 2023. FDA found serious violations of the seafood HACCP regulation in the HACCP plan for fresh and frozen histamine-forming seafood, including mahi-mahi. The plan lacked required hazard listings, critical control points, critical limits, monitoring procedures, and corrective actions, and the firm had not responded to concerns discussed at the end of the assessment.

What FDA found

  1. The HACCP plan did not list Clostridium botulinum growth and toxin formation or undeclared allergens as hazards reasonably likely to occur.

    21 CFR 123.6(c)(1)
  2. The HACCP plan did not include a critical control point at receiving fresh whole gutted mahi-mahi to control histamine formation during transit from local ports to the plant.

    21 CFR 123.6(c)(2)
  3. The HACCP plan did not include a critical control point for fish stored up to 48 hours between layers of ice to control histamine formation.

    21 CFR 123.6(c)(2)
  4. The HACCP plan did not include a sensory examination critical limit at the receiving critical control point to control histamine formation.

    21 CFR 123.6(c)(3)
  5. The monitoring procedures were incomplete: one did not state the number of fish to analyze for histamine, and another did not state the minimum number of fish to temperature-check.

    21 CFR 123.6(c)(4)
  6. The corrective action plan at the receiving critical control point was inadequate when temperature measurements exceeded the critical limit.

    21 CFR 123.7

What FDA wants

FDA tells the company to respond in writing within 15 working days with specific correction steps, a revised HACCP plan, and five consecutive days of completed monitoring records. If corrections cannot be completed in that time, the company must explain the delay and state when it will correct remaining violations.

Who should pay attention

  • U.S. importers of mahi-mahi and other histamine-forming seafood
  • seafood processors and cold-chain suppliers
  • brands sourcing vacuum-packed frozen fish from contract processors

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Ocean Pride Seafood, Inc.

    FDA warned Ocean Pride Seafood that its ready-to-eat seafood was adulterated (unsafe under law) due to missing seafood safety (HACCP) controls and insanitary conditions.

    High risk
  2. Star Ocean Wholesale Foods, Inc.

    FDA warns Star Ocean Wholesale Foods over missing checks for imported fermented fish sauce.

    High risk
  3. South Asian Food Inc.

    South Asian Food Inc. lacked seafood HACCP import verification and pest controls for imported dried seafood.

    High risk
  4. AF Import & Wholesale Co

    FDA warned Houston seafood importer AF Import & Wholesale for missing written verification that its imported fish was processed safely.

    High risk